• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Coenzyme Q10 in Acute Influenza

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses. 2018 Aug 29. doi: 10.1111/irv.12608. [Epub ahead of print]
[h=1]Coenzyme Q10 in Acute Influenza.[/h] Chase M[SUP]1[/SUP], Cocchi MN[SUP]1,[/SUP][SUP]2[/SUP], Liu X[SUP]1[/SUP], Andersen LW[SUP]1,[/SUP][SUP]3[/SUP], Holmberg M[SUP]1,[/SUP][SUP]3[/SUP], Donnino MW[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] The goal of this investigation was to determine if acute influenza infection is associated with depletion of CoQ10 compared to healthy controls and to determine any associations between CoQ10 levels and illness severity and inflammatory biomarkers. Patients and Methods We analyzed serum CoQ10 concentrations of patients with acute influenza enrolled in a randomized clinical trial prior to study drug administration. Patients were enrolled at a single urban tertiary care center over 3 influenza seasons (December 27, 2013 to March31, 2016). Wilcoxon rank sum test was used to compare CoQ10 levels between influenza patients and healthy controls. Correlations with inflammatory biomarkers and severity of illness were assessed using Spearman correlation coefficient. Results We analyzed CoQ10 levels from 50 patients with influenza and 29 controls. Overall, patients with acute influenza had lower levels of CoQ10 (.53ug/mL, IQR .37-.75 vs .72, IQR .58-.90, p=.004). Significantly more patients in the influenza group had low CoQ10 levels (< .5ug/mL) compared to controls (48% vs 7%, p<.001). Among influenza patients, there were significant but weak correlations between CoQ10 levels and IL-2 (r = -.30, p=.04), TNF-alpha (r = -.35, p=.01) and VEGF (r = .38, p=.007), but no correlation with IL-6, IL-10, VCAM or influenza severity of illness score (all p > .05).
[h=4]CONCLUSIONS:[/h] We found that CoQ10 levels were significantly lower in patients with acute influenza infection and that these levels had a significant although weak correlations with several inflammatory biomarkers. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


PMID: 30156030 DOI: 10.1111/irv.12608
Free full text
 
Back
Top Bottom